Vanguard Group’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.84B | Buy |
|
|||||
|
2025
Q1 | $4.14B | Buy |
|
|||||
|
2024
Q4 | $4.16B | Buy |
|
|||||
|
2024
Q3 | $4.4B | Buy |
|
|||||
|
2024
Q2 | $3.43B | Buy |
|
|||||
|
2024
Q1 | $3.52B | Buy |
|
|||||
|
2023
Q4 | $3.05B | Buy |
|
|||||
|
2023
Q3 | $2.6B | Sell |
|
|||||
|
2023
Q2 | $3.84B | Buy |
|
|||||
|
2023
Q1 | $3.84B | Buy |
|
|||||
|
2022
Q4 | $3.44B | Buy |
|
|||||
|
2022
Q3 | $3.55B | Buy |
|
|||||
|
2022
Q2 | $3.37B | Buy |
|
|||||
|
2022
Q1 | $3.85B | Buy |
|
|||||
|
2021
Q4 | $4.07B | Buy |
|
|||||
|
2021
Q3 | $4.1B | Buy |
|
|||||
|
2021
Q2 | $3.8B | Sell |
|
|||||
|
2021
Q1 | $3B | Buy |
|
|||||
|
2020
Q4 | $3.28B | Sell |
|
|||||
|
2020
Q3 | $2.68B | Sell |
|
|||||
|
2020
Q2 | $3.07B | Sell |
|
|||||
|
2020
Q1 | $2.38B | Buy |
|
|||||
|
2019
Q4 | $2.45B | Buy |
|
|||||
|
2019
Q3 | $2.11B | Buy |
|
|||||
|
2019
Q2 | $1.87B | Buy |
|
|||||
|
2019
Q1 | $1.57B | Buy |
|
|||||
|
2018
Q4 | $1.69B | Buy |
|
|||||
|
2018
Q3 | $1.68B | Buy |
|
|||||
|
2018
Q2 | $1.5B | Buy |
|
|||||
|
2018
Q1 | $1.42B | Buy |
|
|||||
|
2017
Q4 | $1.21B | Buy |
|
|||||
|
2017
Q3 | $1.09B | Buy |
|
|||||
|
2017
Q2 | $928M | Buy |
|
|||||
|
2017
Q1 | $830M | Buy |
|
|||||
|
2016
Q4 | $684M | Buy |
|
|||||
|
2016
Q3 | $692M | Sell |
|
|||||
|
2016
Q2 | $738M | Buy |
|
|||||
|
2016
Q1 | $611M | Buy |
|
|||||
|
2015
Q4 | $550M | Buy |
|
|||||
|
2015
Q3 | $511M | Buy |
|
|||||
|
2015
Q2 | $556M | Buy |
|
|||||
|
2015
Q1 | $683M | Buy |
|
|||||
|
2014
Q4 | $500M | Buy |
|
|||||
|
2014
Q3 | $437M | Sell |
|
|||||
|
2014
Q2 | $453M | Buy |
|
|||||
|
2014
Q1 | $395M | Buy |
|
|||||
|
2013
Q4 | $405M | Buy |
|
|||||
|
2013
Q3 | $452M | Buy |
|
|||||
|
2013
Q2 | $382M | Buy |
|